Movement Alert｜Twist Bioscience Corp Rises 5.9% in Regular Trading, AIDD order expectations support rebound

Market Focus11-03 22:38

On November 3, Twist Bioscience Corp rose 5.9% in Regular Trading, trading at $140.9/share, with turnover of $26.5918 million.

The move coincided with renewed market focus on the company’s AI drug discovery opportunity. Publicly available information indicates investors are continuing to trade on expectations tied to large AIDD orders, with one such procurement described as the largest single purchase order in the company’s history, reinforcing attention on medium-term demand expansion.

Earlier disclosures also showed Twist Bioscience Corp agreed to provide antibody characterization data services to Lilly TuneLab, an AI/ML drug discovery platform created by Eli Lilly, linking the company more directly to antibody discovery workflows. Recent analyst initiations were more measured, with Jefferies starting at Hold with a $150 target and UBS at Neutral with a $144 target, suggesting the latest rise is being driven more by demand expectations around AIDD than by a fresh rating upgrade.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment